Tag: biotech
AI Drug Development Faces Reality Check as BigHat CEO Debunks Industry Hype
BigHat Biosciences CEO warns that misconceptions about AI capabilities threaten genuine progress in computational drug discovery. Despite $50 billion annual…
Submit Your Paper to GMJ
No APC until January 2027.